COPD

BALTIMORE, Maryland—The Centers for Medicare & Medicaid Services (CMS) announced it has released its final national coverage determination (NCD) for the treatment of chronic respiratory failure associated with chronic obstructive pulmonary disease (COPD).

GOLETA, California—Inogen Inc., a medical technology company offering respiratory products for the homecare industry, announced it has received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its ‘SIMEOX 200’ airway clearance device. The company said this FDA clearance aims to expand its market and help meet the needs of patients with chronic respiratory diseases.

SAN DIEGO—ResMed announced the results of a study on the global burden of Chronic Obstructive Pulmonary Disease (COPD) through 2050. Published in the Journal of the American Medical Association (JAMA) Network Open, the study found that COPD prevalence among those 25 years and older is expected to increase by 23% from 2020 to 2050, with the largest growth projected among women and within low- and middle-income countries. 
 

CINCINNATI (April 21, 2022)—Quipt Home Medical Corp., a United States-based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced that it has acquired Good Night Medical, LLC, a business with operations across seven U.S. states, for approximately $7 million in Cash. 

LIVINGSTON, Tenn. (June 11, 2021)—Encore Healthcare announced the results from their new oxygen and nebulizer management Nexus TeleRespiratory Care model. Encore used over 20 million data points from chronic respiratory failure patients on home ventilation to build a predictive model that allows home medical equipment (HME) providers to identify when patients need services before they end up in the hospital multiple times.

LONDON, U.K. & PLANO, Texas (May 28, 2021)—Belluscura plc, a medical device developer focused on lightweight and portable oxygen enrichment technology, announced that admission to trading on the Alternative Investment Market (AIM) will take place, and dealings will commence at 8:00 a.m. today under the ticker BELL and ISIN GB00BD3B8Z11. AIM is a sub-market of the London Stock Exchange.

AMSTERDAM (November 17, 2020)—Royal Philips, a global provider of health technology, today announced findings from its first ever World COPD Day survey ahead of the awareness day on November 18. Philips surveyed more than 4,000 adults in China, India, Russia and the U.S. to gather insights on global awareness of respiratory conditions, such as chronic obstructive pulmonary disease (COPD), and how the COVID-19 pandemic has influenced overall perceptions of respiratory health.

AMSTERDAM (July 24, 2020)—Royal Philips, a global provider of health technology, announced the publication of a peer-reviewed, retrospective outcomes study demonstrating that, in the first year of use, high frequency chest wall oscillation therapy (HFCWO) reduced the rate of chronic respiratory patient hospitalization by more than 50%. According to the study, antibiotic use also decreased significantly.

NEW YORK, (April 29, 2020)—AMC Health, a provider of telehealth and remote patient monitoring (RPM) technology, announced its expanded relationship with long-term client Geisinger, utilizing AMC's telehealth capabilities to help assess, monitor and triage patients at-home who are chronically ill and at high risk; those living with heart failure, COPD, hypertension and diabetes.